Another therapeutic option investigated as an anti-calcification agent in PXE models is minocycline, an inhibitor of poly-ADP ribose polymerase 1 (PARP1), a pivotal member of the DNA damage response (DDR). This evidence concerns the gene PARP1 and Pseudoxanthoma elasticum.